Why does microglial BTK activation lead to impaired phagocytosis rather than enhanced clearance function?

OPEN

The study shows BTK activation correlates with impaired microglial phagocytosis in ALS, which contradicts the typical role of kinase activation in enhancing cellular functions. This paradoxical relationship suggests unknown regulatory mechanisms that could be therapeutically targeted to restore microglial clearance capacity. Gap type: contradiction Source paper: BTK inhibition suppresses neuroinflammation and neurodegeneration in amyotrophic lateral sclerosis. (2026, Brain : a journal of neurology, PMID:41710977)

Priority: 0.76 Domain: neuroinflammation Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Why does microglial BTK activation lead to impaired phagocytosis rather than enhanced clearance function? is a 0.76 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Why does microglial BTK activation lead to impaired phagocytosis rather than enhanced clearance function? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (21)

BTKfatty acid oxidationBTKTBK1BTKSTINGBTKAlzheimerBTKAls
▸ Show 16 more

implicated in (1)

BTKALS

inhibits (25)

BTKBcr SignalingSHP1BTKZANUBRUTINIBBTKBTKCancerBTKPyroptosis
▸ Show 20 more

regulates (2)

BTKNF-κBBTKBCR signaling in AQP4-specific B cells

therapeutic target (1)

BTKmantle cell lymphoma
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps